Creative Edge Nutrition Inc. (FITX) Announces the
Post# of 99289
Posted On: 06/09/2014 10:29:59 AM
Creative Edge Nutrition Inc. (FITX) Announces the Appointment of Dr. Sam Alawieh to the Board of Directors
MADISON HEIGHTS, MI / ACCESSWIRE / June 9, 2014 / Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX) is excited and pleased to announce the addition of Dr. Sam Alawieh to our Board of Directors.
Finding his way back home, Windsorite Dr. Sam Alawieh began his educational journey at the University of Windsor. “Bill and I have had many conversations of identifying how to not only contribute back to Windsor & Essex County, but more importantly identify on a global platform the raw talent that exists right here in this city” states Dr. Sam Alawieh. Dr. Alawieh has been instrumental in acquiring and developing local and global talent for Creative Edge Nutrition Inc.
“We are proud to announce the addition of Dr. Sam Alawieh to our Board of Directors. Sam is much more than a great friend, father and who I consider a brother in this great journey as we implement and execute a shared vision of the building of our great company and an industry. Sam has been a valued asset to our company and its shareholders long before his name was ever mentioned publicly. A controversial speaker at times, the genius of Dr. Alawieh comes to light in his many areas of expertise, including but not limited to pharmaceutical compounding, pharmaceutical cGMP and workflow models, brand creation and development, business mergers and acquisitions.
In the coming weeks and months shareholders will learn more about our global footprint and vertical integration for nutrition, industrial hemp and medical marijuana that we have been developing and implementing. Sam and our dynamic team on the US and Canadian sides of the border have been by my side executing our plans daily,” stated President & CEO Bill Chaaban.
BIO FOR DR. SAM ALAWIEH
At a young age, the intellect and genius of Sam Alawieh became evident to his mother and siblings. As a single mother raising five children; Sam like many children in a large family, had to find things to keep himself busy. At the age of 6, he began to read the entire set of Encyclopedia Britannica. He made notes, observations and drawings on the basement wall of their rented home.
Once old enough, Sam began to work multiple jobs to help earn money to contribute to the family’s living expenses. Often at times working two and three jobs while balancing his academics. Sam’s amazing work ethic inspires our team to continue to strive for greatness.
With undergraduate studies in Botany, biochemistry and physics, Sam went on to earn a Doctor of Pharmacology from Ferris State University. Below is a brief sample of Dr. Alawieh’s work experience.
Research, Development & Advanced Practices
Novel Synthesis
Merck & Wayne State University Chemistry Fellowship
High affinity hydroxypiperidine analogues for the dopamine transporter: Stereospecific interactions in vitro and in vivo.
Novel trisubstituted hydroxy piperidine analogs for the dopamine transporter. Drug and Alcohol Dependence.
Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter.
Rxtra Inc.
Novel methodologies for the expedition of cloning sativa indica & hybrid strains.
Novel synthesis of sativa route nutrients through gamma irradiated water system applications with key formulation derivatives.
Investigating cycle acceleration through nutrient peptides of sativa indica & hybrid strains.
Extrapolations of CBD from THC CBD matrix removed from strain during cultivation process.
Hybrid cloning methodologies to establish exponentiated spectrum peaks & troughs of CBD, CBN & THC.
Stabilization of strain activity during maturation processes through sterile carbon filtered environments.
Development
Novel Synthesis of implant vehicle for the subcutaneous transport of marijuana derivatives, hormones, drug addiction & alcohol addiction chemicals.
Novel Synthesis & Development of semi-automated machinery engineered implant vehicle development, Pending Global Patent.
Novel Synthesis & Development of Rectal delivery systems for THC, CBD & Matrix systems.
Novel Synthesis of Buccal delivery systems for THC, CBD & Matrix systems.
Novel engineering of semi-automated sterile units for the production of marijuana strain growth isolators
Novel engineering of gamma irradiation water systems for the engineering of marijuana strain growth isolators
Novel engineering of nutrient matrix feeding systems of marijuana strain growth isolators
Business Development
Compliance Development
Successful facility developments with USP 797, Iso-Class Certifications 1-5, cGMP pharmaceutical manufacturing, state licensures for development and dispensing of pharmaceuticals.
Established medical population base in 42 states & development compliant workflow systems, I.T. systems, & development & dispensing of over 3400 formulations customized to specified disease states.
Systems Development
Custom Portal E-commerce HIPPAA Compliance Medical Record System development of online, drop-shipping, e-commerce, patient-pharmacy-physician communication & ordering capabilities, with API connectivity for but not limited to, existing software for medical marijuana fulfillment etc.
Multiple Diagnostics Ventures
Algorithm Development & Automation of therapeutic Cortisol modalities output in response to direct readings of diagnostic instrumentation of patient salivary hormonal ELISA plates.
Analytics workflow novel development for the matrix readings of but not limited to THC, CBD, CBN potency, sterility & composition over time utilizing USP governance.
Network Development
Establishment of operational workflow & sales force recruitment for the development of a successful nationwide sales force group representing multiple niche lines in pharmaceutical and medical industries in an effort to establish brand recognition and visibility.
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.
MADISON HEIGHTS, MI / ACCESSWIRE / June 9, 2014 / Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX) is excited and pleased to announce the addition of Dr. Sam Alawieh to our Board of Directors.
Finding his way back home, Windsorite Dr. Sam Alawieh began his educational journey at the University of Windsor. “Bill and I have had many conversations of identifying how to not only contribute back to Windsor & Essex County, but more importantly identify on a global platform the raw talent that exists right here in this city” states Dr. Sam Alawieh. Dr. Alawieh has been instrumental in acquiring and developing local and global talent for Creative Edge Nutrition Inc.
“We are proud to announce the addition of Dr. Sam Alawieh to our Board of Directors. Sam is much more than a great friend, father and who I consider a brother in this great journey as we implement and execute a shared vision of the building of our great company and an industry. Sam has been a valued asset to our company and its shareholders long before his name was ever mentioned publicly. A controversial speaker at times, the genius of Dr. Alawieh comes to light in his many areas of expertise, including but not limited to pharmaceutical compounding, pharmaceutical cGMP and workflow models, brand creation and development, business mergers and acquisitions.
In the coming weeks and months shareholders will learn more about our global footprint and vertical integration for nutrition, industrial hemp and medical marijuana that we have been developing and implementing. Sam and our dynamic team on the US and Canadian sides of the border have been by my side executing our plans daily,” stated President & CEO Bill Chaaban.
BIO FOR DR. SAM ALAWIEH
At a young age, the intellect and genius of Sam Alawieh became evident to his mother and siblings. As a single mother raising five children; Sam like many children in a large family, had to find things to keep himself busy. At the age of 6, he began to read the entire set of Encyclopedia Britannica. He made notes, observations and drawings on the basement wall of their rented home.
Once old enough, Sam began to work multiple jobs to help earn money to contribute to the family’s living expenses. Often at times working two and three jobs while balancing his academics. Sam’s amazing work ethic inspires our team to continue to strive for greatness.
With undergraduate studies in Botany, biochemistry and physics, Sam went on to earn a Doctor of Pharmacology from Ferris State University. Below is a brief sample of Dr. Alawieh’s work experience.
Research, Development & Advanced Practices
Novel Synthesis
Merck & Wayne State University Chemistry Fellowship
High affinity hydroxypiperidine analogues for the dopamine transporter: Stereospecific interactions in vitro and in vivo.
Novel trisubstituted hydroxy piperidine analogs for the dopamine transporter. Drug and Alcohol Dependence.
Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter.
Rxtra Inc.
Novel methodologies for the expedition of cloning sativa indica & hybrid strains.
Novel synthesis of sativa route nutrients through gamma irradiated water system applications with key formulation derivatives.
Investigating cycle acceleration through nutrient peptides of sativa indica & hybrid strains.
Extrapolations of CBD from THC CBD matrix removed from strain during cultivation process.
Hybrid cloning methodologies to establish exponentiated spectrum peaks & troughs of CBD, CBN & THC.
Stabilization of strain activity during maturation processes through sterile carbon filtered environments.
Development
Novel Synthesis of implant vehicle for the subcutaneous transport of marijuana derivatives, hormones, drug addiction & alcohol addiction chemicals.
Novel Synthesis & Development of semi-automated machinery engineered implant vehicle development, Pending Global Patent.
Novel Synthesis & Development of Rectal delivery systems for THC, CBD & Matrix systems.
Novel Synthesis of Buccal delivery systems for THC, CBD & Matrix systems.
Novel engineering of semi-automated sterile units for the production of marijuana strain growth isolators
Novel engineering of gamma irradiation water systems for the engineering of marijuana strain growth isolators
Novel engineering of nutrient matrix feeding systems of marijuana strain growth isolators
Business Development
Compliance Development
Successful facility developments with USP 797, Iso-Class Certifications 1-5, cGMP pharmaceutical manufacturing, state licensures for development and dispensing of pharmaceuticals.
Established medical population base in 42 states & development compliant workflow systems, I.T. systems, & development & dispensing of over 3400 formulations customized to specified disease states.
Systems Development
Custom Portal E-commerce HIPPAA Compliance Medical Record System development of online, drop-shipping, e-commerce, patient-pharmacy-physician communication & ordering capabilities, with API connectivity for but not limited to, existing software for medical marijuana fulfillment etc.
Multiple Diagnostics Ventures
Algorithm Development & Automation of therapeutic Cortisol modalities output in response to direct readings of diagnostic instrumentation of patient salivary hormonal ELISA plates.
Analytics workflow novel development for the matrix readings of but not limited to THC, CBD, CBN potency, sterility & composition over time utilizing USP governance.
Network Development
Establishment of operational workflow & sales force recruitment for the development of a successful nationwide sales force group representing multiple niche lines in pharmaceutical and medical industries in an effort to establish brand recognition and visibility.
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.
(0)
(0)